| Name | (3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol |
|---|---|
| Synonyms |
IFM
5-HYDROXYMETHYL-3,4-DIHYDROXYPIPERIDINE (3R,4R,5S)-5-(Hydroxymethyl)piperidine-3,4-diol 5-epi-Isofagomine 3,4-Piperidinediol, 5-(hydroxymethyl)-, (3R,4R,5S)- iso-Fagomine (3R,4R,5S)-5-(Hydroxymethyl)-3,4-piperidinediol 1oif D-Isofagomine Afegostat |
| Description | Afegostat was previously in phase II clinical trials for the treatment of Gaucher's disease. The experiment was discontinued. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 317.2±37.0 °C at 760 mmHg |
| Molecular Formula | C6H13NO3 |
| Molecular Weight | 147.17 |
| Flash Point | 171.8±17.1 °C |
| PSA | 72.72000 |
| LogP | -1.80 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.535 |
| Precursor 7 | |
|---|---|
| DownStream 0 | |